Mumbai,India

Author: admin

Maithili Life Sciences, TCG Lifesciences, Sipra labs, HINQ Pharma-CRO, Auriga Research, Edenwell Therapeutics are in the race for the coveted Pharma Leaders Most Promising & Valuable Company in Contract Research 2018

October 27, 2018

Maithili Life Sciences, TCG Lifesciences, Sipra labs, HINQ Pharma-CRO, Auriga Research, Edenwell Therapeutics are in the race for the coveted Pharma Leaders Most Promising & Valuable Company in Contract Research 2018 Drugs worth an estimated $137 billion are scheduled to go off-patent in US and Europe over the next 5 years. India is poised to…
Read more

Dr.D. Nageshwara Reddy, Dr.Tehemton Erach Udwadia, Dr.K.R.Palanisamy, Dr.Amit Prabhakar Maydeo, Dr.Thoguluva Shesadri Chandrasekar & Dr.Randhir Sud are top six finalists for the coveted “Pharma Leaders Indian of the Year – Gastroenterology” at Pharma Leaders Power Brand Awards 2018

October 10, 2018

Dr.D. Nageshwara Reddy, Dr.Tehemton Erach Udwadia, Dr.K.R.Palanisamy, Dr.Amit Prabhakar Maydeo, Dr.Thoguluva Shesadri Chandrasekar & Dr.Randhir Sud are top six finalists for the coveted “Pharma Leaders Indian of the Year – Gastroenterology” at Pharma Leaders Power Brand Awards 2018 Credibility & prestigious are the hallmarks of the pharma leaders awards.Extennsive research & meticulous study by Network…
Read more

E-Pharmacy in India. Can Patient Safety & Drug abuse be compromised without solid medical supervision?

September 28, 2018

E-Pharmacy in India. Can Patient Safety & Drug abuse be compromised without solid medical supervision?. The All india Organisation of Chemist and Druggist (AIOCD) has called for a nationwide strike protesting strongly against the government’s decision, stating e-pharmacy poses threat to their business and could lead to the risk of drug abuse. In india there…
Read more

Indian Government bans 329 fixed drug combinations (FDC), Pharma Companies suffer a major setbacks, healthcare activists celebrate!

September 14, 2018

The government on Wednesday prohibited the manufacture, sale or distribution of 328 fixed dose combination (FDC) drugs for human use with immediate effect, thereby settling the dust on the fate of “irrational” FDCs. It also restricted the manufacture, sale or distribution of six other FDCs in respect to specific indications subject to certain conditions. Painkillers,…
Read more

Indian Healthcare Sector needs a healing Touch!

September 8, 2018

Healthcare is a fast growing field, promising   ample employment opportunities. The industry’s turnover by 2020 is estimated at $280 billion. An annual growth rate (CAGR) of 16.5 per cent has necessitated the need for a proper policy framework, adequate infrastructure and skilled human resources for the sector. While the domain pledges to generate employment, it…
Read more

Modicare in India : Will India see the impact?

September 8, 2018

Prime Minister Narendra Modi’s Independence Day speech was headlined by the announcement of the Pradhan Mantri Jan Arogya Abhiyan, previously Ayushman Bharat. The National Health Protection Mission (NHPM), or “Modicare”, will roll out on 25 September. It is expected to provide basic health insurance cover for 100 million families, based on a range of socioeconomic…
Read more

Transforming the Indian Healthcare Sector : The Road Ahead!

September 8, 2018

Ever increasing aging and young population, low penetration and high prices of medicines and healthcare services, ambiguous policies, and insufficient health insurance coverage for most citizens has posed a multi-pronged challenge for the Indian healthcare sector. The irony is that on one hand, we aim to replicate world class medical research and care centers like…
Read more

Recent Comments
    Categories

    ©  2024 pharmaleaders2018. Built using WordPress and the Mesmerize Theme